Publikasi

Pharma Friday – January 9, 2026

An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and ...

People with Obesity May Have a Higher Risk of Dementia

People with obesity and high blood pressure may face a higher risk of dementia, ...

New Research Connections: How dkNET Allows Access to th...

Endocrine scientists around the world can now access dkNET, a research portal es...

COVID-19 Infection Linked to Relapse of Rare Endocrine ...

A rare case study published in JCEM Case Reports details the first known instanc...

New Study Links Combination of Hormone Therapy and Tirz...

A new study led by Mayo Clinic found that postmenopausal women receiving menopau...

New Study May Offer Hope to Women Suffering Menopausal ...

A woman’s insulin levels in midlife are linked to the timing and duration of men...

The Butterfly Effect: JCEM CR Studies Connect the Heart...

Nicknamed the “butterfly gland” due to its shape, the thyroid’s impact on the bo...

Society Advocates for NIH Funding as Next Year’s Budget...

As this article went to press, Congress has yet to complete a full-year spending...

And Just Like That, It’s 2026!

As we leave 2025 behind and look forward to the new year ahead, what better way ...

Novo Nordisk’s OASIS 4 Study Validates Daily Oral Pill ...

A new year brings a new therapeutic milestone for weight management: Following i...

Endocrine Society Launches Rare Endocrine Disease Fello...

The Endocrine Society is pleased to announce its Rare Endocrine Disease (RED) Fe...

Lilly’s Oral GLP-1 Orforglipron Demonstrates Superiorit...

Eli Lilly’s “Ozempic-in-a-pill” candidate just cleared its most significant clin...

Compare and Contrast: As Glucagon-Like Peptide-1 Recept...

As the onslaught of anti-obesity drugs hit the market in recent years, more rese...

Beyond the Scale: What Else Glucagon-like Peptide-1 Rec...

In the United States, American Heart Month is observed in February to raise awar...

New Research Challenges Fears of Semaglutide-Linked Thy...

The “black box” warning on the popular diabetes and weight loss drug semaglutide...

Both Ends of the Spectrum: Talking Obesity Science with...

The Endocrine Society’s 2026 recipient of the Outstanding Clinical Investigator ...